1371P Assessment of whether time to docetaxel impacts outcome when given in metastatic hormone-sensitive prostate cancer (MHSPC) setting

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 33; pp. S1168 - S1169
Main Authors George, S., Gosain, R., Yendamuri, K., Boher, J.M., Gravis Mescam, G., Sweeney, C.J., Hutson, A.
Format Journal Article
LanguageEnglish
Published 01.09.2022
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
DOI:10.1016/j.annonc.2022.07.1503